AusPAR: Adalimumab

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

25 August 2014
AusPAR Details
AusPAR
AusPAR: Adalimumab (pdf, 954 KB)
AusPAR: Adalimumab (docx, 1 MB)
Attachment: Product Information: Adalimumab (pdf, 569 KB)
Attachment: Adalimumab (docx, 416 KB)
Attachment: Extract from the Clinical Evaluation Report: Adalimumab (pdf, 468 KB)
Attachment: Extract from the Clinical Evaluation Report: Adalimumab (docx, 1 MB)
Active Ingredient
Adalimumab
Product Name
Humira
Sponsor
AbbVie Pty Ltd
Submission Number
PM-2013-01154-1-1
Submission Type
Extension of indications, New strength
Decision
Approved
AusPAR Date
5 August 2014
Publication Date

25 August 2014
Tags: 
medicines, AusPARs
URL: 
https://www.tga.gov.au/node/188489